Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion

Future Oncology, Ahead of Print.

Source: Future Oncology - August 22, 2023 Category: Cancer & Oncology Authors: Roberta Caputo Giuseppe Buono Vincenzo Di Lauro Daniela Cianniello Claudia Von Arx Matilde Pensabene Martina Pagliuca Carmen Pacilio Francesca Di Rella Annarita Verrazzo Claudia Martinelli Francesco Nuzzo Michelino De Laurentiis Source Type: research